Illustrate the mechanism of action of sulfonic urea used as oral hypoglycemic agents. Enumerate the role of insulin on glucose utilization.

MOA of Sulfonyl Acid Derivatives

Sulfonylureas (Tolbutamide, Chlorpropamide), a class of sulfonyl acid derivatives, have a significant action in lowering blood glucose levels in normal subjects and in type 2 diabetics.

The mechanism of action of sulfonylureas involves provoking a brisk release of insulin from the pancreas.

MOA: 

(1) They act on the so-called ‘sulfonylurea receptors’ (SUR1) on the pancreatic β cell membrane. 

(2) This action causes depolarization by reducing the conductance of ATP-sensitive K+ channels. (Raised ATP production followed by raised Glucose also reduces the conductance of ATP sensitive K+ Channels)

(3) This process enhances Ca2+ influx (Followed by the stimulation of Voltage sensitive Ca++ Channel) and degranulation (followed by calcium dependent translocation), which increases the rate of insulin secretion.

Please note that sulfonylureas are only effective when the patient has some residual pancreatic beta cell activity.

They do not cause hypoglycemia in pancreatectomized animals and in type 1 diabetics. 

ROLE of INSULIN in GLUCOSE UTILIZATION

Insulin plays a crucial role in regulating glucose uptake and utilization throughout the body. It acts as a key hormone in maintaining blood glucose homeostasis.

Primary Mechanism of Insulin in Glucose Utilization:

Glucose Absorption: When carbohydrates are consumed, body breaks them down into glucose, a simple sugar that serves as a vital energy source. 

(a) Insulin attaches to insulin receptors of the target cell.
(b) Activates a cascade of signaling leading to the formation of certain protein called GLUT4 which is a glucose transporter protein, 
(c) GLUT4 is then translocated to the Plasma membrane and Transport glucose into the cell.
(d) Inside the cell Glucose converted to Glucose-6-phosphate which is used as a source of energy. 
- In that way the glucose absorption pathway is regulated by the action of Insulin. 



  • Facilitates glucose uptake by cells: above MECHANISM

  • Promotes glycogen synthesis in the liver: Insulin stimulates the enzyme glycogen synthase, which promotes the conversion of glucose into glycogen for storage in the liver. This helps to lower blood glucose levels after a meal.

  • Inhibits glycogenolysis in the liver: Glycogenolysis is the process of breaking down glycogen into glucose. Insulin inhibits this process by activating an enzyme called protein phosphatase I (PP1), which dephosphorylates and inactivates glycogen phosphorylase, the enzyme responsible for glycogen breakdown.

  • Inhibits lipolysis in adipose tissue: Insulin inhibits lipolysis by inhibiting hormone-sensitive lipase (HSL), the enzyme responsible for triglyceride breakdown. This prevents the release of fatty acids into the bloodstream.

 


Comments

Post a Comment

Popular posts from this blog

Image
MOA of Nitroglycerine  Nitroglycerine converted to NO (Active Metabolite)  NO bonds with Guanylyl cyclase and catalyzes the conversion of GTP to cyclic GMP. cGMP induces the enzyme Myosin LC phosphatase  Myosin-LC phosphatase dephosphorylates the phosphorylated myosin-LC (Contraction) to Myosin-LC (Relaxation)  Reducing Preload : Vasodilation promotes peripheral pooling of blood and decreases venous return to the heart , reducing preload. This results in decreased myocardial oxygen demand. Reducing Afterload : Arteriolar relaxation reduces systemic vascular resistance and arterial pressure, also known as afterload. This decreases the resistance the heart must overcome to eject blood, which reduces the workload of the heart. 
Read more
Image
Illustrate the overview of the different classes of anti-anginal drugs and discuss their specific mechanisms of action and indications for use? Classification of Antianginal Drugs MODE of ACTION  Organic Nitrates: (Increasing O2 Supply)           MOA (Vein)            Calcium Channel Blockers: (Increasing O2 supply & Decreasing O2 Demand)          MOA - CLICK HERE         In case of the smooth muscles of coronary artery , the CCBs prevents the contraction of arterial smooth muscle leading to Arterial Dilation . → Increased  O2 Supply   In Case of Cardiac smooth muscle , CCBs prevents the contraction (inhibiting the formation of MLCK+ ) results in Negative inotropic effect ( Decreased Force of Contraction ) in Heart. Potassium Channel Opener: (Increased O2 Supply)           MOA -            Beta Blockers: (Decreasing O2 Demand)           MOA -  Block the  adrenergic  beta (BETA 2) receptor of the heart leading to Decreased sympathetic outflow leading to Decreased HR (Negativ
Read more
Image
Explain in detail the role of prostacyclin and thromboxane on platelet aggregation Prostacyclin and thromboxane are two opposing eicosanoids (locally-acting hormones) that play a critical role in platelet aggregation. These 2 Local hormones are produced in the Arachidonic Acid Metabolism Pathway. Role of TXA2 on platelet Aggregation: Thromboxane A2 is produced from Prostaglandin H2 by the Enzyme Thromboxane A synthase. Mature platelets express only COX-1 and releases TxA2. This TxA2 then binds with TP receptor and induces platelet Aggregation by Protein Kinase C Dependent pathways . ( increased Stickiness) PGI2 also binds with TP receptor of Vascular smooth muscle inhibiting PKC pathway causing increased cAMP level causing Vasoconstriction.   The role of TXA2 in platelet aggregation is so important that aspirin, which inhibits TXA2 production by blocking the cyclooxygenase-1 (COX-1) enzyme, is one of the most widely used antiplatelet drugs in the world. Aspirin is used to prevent
Read more